Hualan Biological Engineering Inc

002007

Company Profile

  • Business description

    Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, recombinant proteins, and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin, and others. The vaccine products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine, and others. It also offers gene products such as Monoclonal Antibodies for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.

  • Contact

    No. 1, Hualan Avenue
    Henan Province
    Xinxiang453003
    CHN

    T: +86 3733559989

    http://www.hualanbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    4,012

Stocks News & Analysis

stocks

Our three most overvalued ASX shares

These three companies are trading at a significant premium to our fair value.
stocks

What does big US court decision mean for Google’s parent company Alphabet?

Alphabet shares popped 7% after the ruling on September 2 and have now rallied by around 50% since April.
stocks

Our only 5-star wide moat ASX share

A difficult year but better times ahead.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,122.007.40-0.08%
CAC 407,674.7824.14-0.31%
DAX 4023,596.98173.35-0.73%
Dow JONES (US)45,400.86220.43-0.48%
FTSE 1009,208.218.66-0.09%
HKSE25,486.9468.960.27%
NASDAQ21,700.397.30-0.03%
Nikkei 22543,669.26650.511.51%
NZX 50 Index13,260.6837.150.28%
S&P 5006,481.5020.58-0.32%
S&P/ASX 2008,846.608.60-0.10%
SSE Composite Index3,818.826.310.17%

Market Movers